Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy

about

Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: a retrospective observational study in Southern Italy

Item

http://www.wikidata.org/entity/Q57817732

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Predictors of new oral anticoa ...... tional study in Southern Italy

@en

Predictors of new oral anticoa ...... tional study in Southern Italy

@nl

type

Item

label

Predictors of new oral anticoa ...... tional study in Southern Italy

@en

Predictors of new oral anticoa ...... tional study in Southern Italy

@nl

prefLabel

Predictors of new oral anticoa ...... tional study in Southern Italy

@en

Predictors of new oral anticoa ...... tional study in Southern Italy

@nl

P1476

Predictors of new oral anticoa ...... tional study in Southern Italy

@en

P2093

Annalisa Capuano

http://www.w3.org/2001/XMLSchema#string

Cristina Scavone

http://www.w3.org/2001/XMLSchema#string

Francesca Guerriero

http://www.w3.org/2001/XMLSchema#string

Francesca Maria Colaccio

http://www.w3.org/2001/XMLSchema#string

Valeria Marina Monetti

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature

Dabigatran versus warfarin in patients with atrial fibrillation

Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Apixaban versus warfarin in patients with atrial fibrillation

Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.

Why do patients with atrial fibrillation not receive warfarin?

P304

1907-1914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S171346

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Enrica Menditto

Maurizio Sessa

Valentina Orlando

P577

2018-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349269

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

6183659

http://www.w3.org/2001/XMLSchema#string